Vanguard Group
CVRX icon

Vanguard Group’s CVRx CVRX Stock Holding History

Vanguard Group’s Portfolio CVRX Stock Details CVRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$7.96M Buy
1,120,663
+30,437
+3% +$278K ﹤0.01% 3073
2025
Q3 		$8.8M Buy
1,090,226
+12,948
+1% +$97.4K ﹤0.01% 3045
2025
Q2 		$6.33M Buy
1,077,278
+70,559
+7% +$487K ﹤0.01% 3125
2025
Q1 		$12.3M Buy
1,006,719
+97,209
+11% +$1.37M ﹤0.01% 2734
2024
Q4 		$11.5M Buy
909,510
+85,220
+10% +$1.05M ﹤0.01% 2876
2024
Q3 		$7.26M Buy
824,290
+160,787
+24% +$1.46M ﹤0.01% 3112
2024
Q2 		$7.96M Buy
663,503
+69,191
+12% +$797K ﹤0.01% 3040
2024
Q1 		$10.8M Buy
594,312
+31,720
+6% +$751K ﹤0.01% 2917
2023
Q4 		$17.7M Buy
562,592
+12,564
+2% +$236K ﹤0.01% 2649
2023
Q3 		$8.34M Buy
550,028
+1,714
+0.3% +$28.2K ﹤0.01% 2980
2023
Q2 		$8.47M Buy
548,314
+54,981
+11% +$671K ﹤0.01% 3041
2023
Q1 		$4.6M Buy
493,333
+46,098
+10% +$610K ﹤0.01% 3347
2022
Q4 		$8.21M Buy
447,235
+14,915
+3% +$184K ﹤0.01% 3044
2022
Q3 		$4.03M Sell
432,320
-12,048
-3% -$95.4K ﹤0.01% 3425
2022
Q2 		$2.67M Sell
444,368
-19,567
-4% -$113K ﹤0.01% 3681
2022
Q1 		$2.78M Buy
463,935
+69,718
+18% +$563K ﹤0.01% 3815
2021
Q4 		$4.82M Sell
394,217
-290,074
-42% -$4.21M ﹤0.01% 3633
2021
Q3 		$11.3M Buy
684,291
+635,531
+1,303% +$12.2M ﹤0.01% 3168
2021
Q2 		$1.37M Buy
+48,760
New +$1.37M ﹤0.01% 4078

Other funds holding CVRX

JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GP
GSK plc London $599M AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group's CVRX Position: Q4 2025 in Review

Vanguard Group increased its CVRx (CVRX) stake by 2.8% in Q4 2025, buying an estimated $278K and bringing the position to 1,120,663 shares worth $7.96M. The position accounts for ﹤0.01% of the portfolio, ranked #3073.

Vanguard Group first reported a position in CVRX in Q2 2021 and has held it in 19 quarters since. The position peaked at $17.7M in Q4 2023. 92 funds tracked by Wall St. Rank hold CVRX as of Q4 2025.

  • Vanguard Group held 1,120,663 shares of CVRx worth $7.96M as of Q4 2025.
  • Vanguard Group bought 30,437 CVRx shares in Q4 2025, an estimated $278K.
  • CVRx made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #3073 holding.
  • Vanguard Group first reported a position in CVRx in Q2 2021 and has held it in 19 quarters since.
  • Vanguard Group's CVRx position peaked at $17.7M in Q4 2023.
  • 92 funds tracked by Wall St. Rank held CVRx as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.